Study on the Health Economic Burden of Alzheimer's Disease in China
ConditionAlzheimer Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-100
SponsorXuanwu Hospital, Beijing
About this trial
Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.
Eligibility criteria
Qualifiers
None
Disqualifiers
History of stroke with neurological focal signs and imaging findings consistent with cerebral small vessel disease (Modified Fazekas score ≥2).
Presence of mental or neurological developmental delay.
Presence of other known conditions that may cause cognitive impairment.
Diagnosis of a disease that prevents completion of cognitive assessments.
Trial design
Treatments tested in this trial
- There was no intervention as this was an observational study.
Treatment groups
9,510 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov